Novo CEO indicates potential mergers and acquisitions to bolster its drug pipeline and combat rising competition in the weight-loss market.
Read More

Novo CEO indicates potential mergers and acquisitions to bolster its drug pipeline and combat rising competition in the weight-loss market.
Read More